Management of bronchovascular mucormycosis in a diabetic: a surgical success.
Although cases of pulmonary mucor are scarce, diabetics account for a large percentage of these patients. The synergism of diabetes mellitus and mucormycosis poses potentially devastating bronchopulmonary complications, warranting urgent intervention. This report reviews the efficient workup, along with successful medical and surgical management, of a patient with pulmonary mucormycosis, with evidence of superior vena cava invasion.
Reid
Vincent J
VJ
Department of Surgery, Coney Island Hospital, Brooklyn, New York 11235, USA.
Solnik
Deborah L
DL
Daskalakis
Theodoris
T
Sheka
Kedambady P
KP
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D048909:Diabetes Complications / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D009894:Opportunistic Infections / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D011013:Pneumonectomy; D012907:Smoking; D014057:Tomography, X-Ray Computed; D014683:Vena Cava, Superior / Q000382:microbiology / Q000601:surgery*
D000935:Antifungal Agents; D000666:Amphotericin B